Overview
Find detailed information on a selected clinical trials for Acute Myeloid Leukemia and Myelodysplasia – Therapy for New Diagnosis High Risk Disease at Cincinnati Children's Hospital Medical Center.
There are two versions of some of the trials. While they contain the same basic information, one version is geared toward healthcare professionals and the other is geared toward families.
| Trial | Healthcare Professional Version | Family-Friendly Version |
|---|
| AAML0531: A Phase III Randomized Trial of Gemtuzumab Ozogamicin (Mylotarg") Combined with Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML) in Children, Adolescents, and Young Adults |
Professional |
Not Available |
| AAML05P1: A Phase II Pilot Study of Killer Immunoglobulin-Like Receptor-Incompatible Unrelated Donor Hematopoietic Cell Transplantation in Young Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia |
Professional |
Not Available |
